Effect of Age on Effectiveness of Vonoprazan in Triple Therapy for <i>Helicobacter pylori</i> Eradication-Reference-Cited by-同舟云学术

Effect of Age on Effectiveness of Vonoprazan in Triple Therapy for Helicobacter pylori Eradication

Published:2019-06-01 Issue:11 Volume:58 Page:1549-1555
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Kusunoki Maho¹²,Yuki Mika¹,Ishitobi Hitomi¹,Kobayashi Yoshiya¹,Nagaoka Makoto¹,Takahashi Yoshiko¹,Fukuba Nobuhiko¹,Komazawa Yoshinori¹,Shizuku Toshihiro¹,Kinoshita Yoshikazu²

Affiliation:

1. Department of Internal Medicine, Izumo City General Medical Center, Japan

2. Department of Gastroenterology and Hepatology, Shimane University School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/58/11/58_2233-18/_pdf

Reference25 articles.

1. 1. Murakami K, Sakurai Y, Shiino M, Funao N, Nishimura A, Asaka M. Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study. Gut 65: 1439-1446, 2016.

2. 2. Jung YS, Kim EH, Park CH. Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication. Aliment Pharmacol Ther 46: 106-114, 2017.

3. 3. Tsujimae M, Yamashita H, Hashimura H, et al. A comparative study of a new class of gastric acid suppressant agent named vonoparazan versus esomeprazole for the eradication of Helicobacter pylori. Digestion 94: 240-246, 2016.

4. 4. Yamada S, Kawakami T, Nakatsugawa Y, et al. Usefulness of vonoprazan, a potassium ion-competitive acid blocker, for primary eradication of Helicobacter pylori. World J Gastrointest Pharmacol Ther 7: 550-555, 2016.

5. 5. Sue S, Kuwashima H, Iwata Y, et al. The superiority of vonoprazan-based first-line triple therapy with clarithromycin: a prospective multicenter cohort study on Helicobacter pylori eradication. Intern Med 56: 1277-1285, 2017.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review on the Efficacy and Safety of Vonoprazan in the Management of Gastric Acid-Related Diseases;Cureus;2024-07-17

2. Novel therapeutic regimens against Helicobacter pylori: an updated systematic review;Frontiers in Microbiology;2024-06-07

3. Effect of Concomitant Use of Polaprezinc and Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication;Gastroenterology Insights;2024-05-11

4. Vonoprazan a novel potassium competitive acid blocker; another leap forward;Gastroenterology Review;2024

5. Eradication of Helicobacter pylori may improve dyspepsia in the elderly for the long term;BMC Gastroenterology;2021-11-25